33 / 60
31
PROGRAMME & EXHIBITION GUIDE |
POSTERS
Prognostic role of FDG-PET metabolic parameters during radiotherapy for head
and neck squamous cell carcinoma
M. Min (Australia), P. Lin, M. Lee, I. Ho Shon, M. Lin, D. Forstner, V. Bray, A. Chicco,
M.T. Tieu,
A.
Fowler
PO-118
Does adaptive threshold based MTV and SUL have predictive value in head-neck
cancers treated with radiotherapy?
O. Ozkaya Akagunduz (Turkey), R. Savas, K. Kocacelebi, S. Alanyali, M. Esassolak
PO-119
Clinical impact of metabolic and anatomic imaging in nasopharyngeal carcinoma
treated with chemo-radiotherapy
S. Ghosh Laskar (India), A. Pilar, N. Purandare, V. Rangarajan, A. Budrukkar,
T. Gupta, V. Murthy
PO-120
Computer-aided quantitative interpretation to HIF-1a, c-MYC and p53 expression
in oral submucous fibrosis
A. Anura (India), S. Conjeti, M. Pal, R.R. Paul, J. Chatterjee
PO-121
Poster
SUPPORTIVE CARE, QUALITY OF LIFE, REHABILITATION
Pre-radiation feeding tube marks a poor prognostic subset of postoperative p16+
oropharyngeal cancer
V. Verma (USA), J. Liu, J.S. Lewis, D.R. Adkins, B. Nussenbaum, W.L. Thorstad, H. Gay
PO-122
Bupivacaine lozenge induces no risk of toxic plasma concentration in healthy sub-
jects and head and neck cancer patients
C. Treldal (Denmark), S. Mogensen, K. Sveindottir, K. Jensen, C.A. Kristensen,
J. Jacobsen, M. Kreilgaard, J. Petersen, O. Andersen
PO-123
New local anesthetic lozenge induces no risk of aspiration in healthy subjects and
head and neck cancer patients
S. Mogensen (Denmark), K. Sveindottir, C. Treldal, A. Nygaard, A. Mohammad,
C.A. Kristensen,
J.
Petersen, O. Andersen
PO-124
Toxicity and feasibility of adjuvant chemotherapy in nasopharynx carcinoma:
A retrospective study
P. Winckler (Portugal), I. Sargento, M. Ferreira, S. Esteves, D. Costa, J. Mouta,
E. Gouveia, A.
Mo
reira
PO-125